US Patent Issued to UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION on Jan. 20 for "Therapy for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP)" (Pennsylvania Inventors)

Posted On: 2026-01-20

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,808, issued on Jan. 20, was assigned to UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh).

"Therapy for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP)" was invented by Xiaochao Ma (Sewickley, Pa.), Junjie Zhu (Pittsburgh) and Jie Lu (Wexford, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are novel compositions and methods of using the same for the treatment of Erythropoiefic protoporphyria (EPP) and X-linked protoporphyria (XLP). Disclosed are methods and compositions related to treating Erythropoietic protoporphyria and X-linked protoporphyria. Also described are therapeutic a...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION on Jan. 20 for "Therapy for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP)" (Pennsylvania Inventors)